Blood test could identify fetal father without amniocentesis

NCT ID NCT06864806

Recruiting now Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to develop a non-invasive blood test that analyzes fetal DNA found in the mother's blood to determine paternity. It is designed for sexual assault victims who become pregnant and need to know the father's identity for legal reasons. The test uses a technique called massively parallel sequencing and will be tested on 60 pregnant women and their potential fathers. If successful, it could replace invasive procedures like amniocentesis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a reliable, non-invasive way to determine fetal paternity in criminal cases, helping victims avoid invasive procedures.
What could go wrong: This is a small, early-stage method development study (60 participants). The technique may not be accurate enough or may fail to work in all cases. Results are for forensic use only, not a medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY RELATED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREGNANCY RELATED

Contacts and locations

Locations

CHU Bordeaux
RECRUITING

Bordeaux, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.